Market Place
Sourcing Support
All News #Library
Biotech
Lupin Pharma`s Manufacturing Arm Expands Dabhasa Facility
20 Mar 2026 //
PRESS RELEASE
Lupin, TB Alliance Partner To Advance Telacebec For TB Treatment
02 Feb 2026 //
PRESS RELEASE
Lupin Receives Positive CHMP Opinion For Biosimilar Ranibizumab
18 Dec 2025 //
PRESS RELEASE
Lupin Inks Exclusive U.S. Licensing Deal For Armlupeg
06 Dec 2025 //
PRESS RELEASE
Lupin Receives FDA Approval For Biosimilar Armlupeg
01 Dec 2025 //
INDPHARMAPOST
Lupin Presents Phase 1 Data On LNP3693 At ESMO Congress 2025
13 Oct 2025 //
PR NEWSWIRE
Lupin and Sadoz Partner to Market Ranibizumab Biosimilar
12 Aug 2025 //
INDPHARMAPOST
Zentiva, Lupin Ink Deal for Tnf Alpha Inhibitor Biosimilar Supply
09 Jul 2025 //
PR NEWSWIRE
Lupin Launches Ipratropium Nasal Spray in Two Strengths
05 Jul 2025 //
EXPRESSPHARMA
Lupin Deal to Supply Biosimilar Ranibizumab in Latin America
26 May 2025 //
ECONOMICTIMES
Lupin launches Ganirelix Acetate Injection in US
15 Feb 2024 //
INDIAN PHARMA POST
Lupin Partners Enzene to roll out biosimilar Cetuximab here
31 May 2023 //
ECONOMIC TIMES
Lupin launches biosimilar cetuximab in pact with Enzene
30 May 2023 //
ECONOMICTIMES
Lupin Announces Health Canada Approval of Tiotropium Bromide for COPD
27 May 2023 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.